{"transactions":[{"id":2925606,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":144232,"kind":"person","name":"Jenkins Kimble L.","position":1,"cik":"0001492392","reported_name":"Jenkins Kimble L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-04T18:36:43.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":208,"price":15,"value":3120.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $15.00 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended December 31, 2020."}],"balance_after":49251,"source":{"system":"sec-edgar","filing":"0001420506-21-000010","document":"doc4_894.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492392/000142050621000010/doc4_894.xml","form_type":"4"}},{"id":3018550,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":144232,"kind":"person","name":"Jenkins Kimble L.","position":1,"cik":"0001492392","reported_name":"Jenkins Kimble L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-01T18:10:55.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":547,"price":5.71,"value":3123.37,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $5.71 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended September 30, 2020."}],"balance_after":49043,"source":{"system":"sec-edgar","filing":"0001420506-20-001037","document":"doc4_857.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492392/000142050620001037/doc4_857.xml","form_type":"4"}},{"id":3091798,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":144232,"kind":"person","name":"Jenkins Kimble L.","position":1,"cik":"0001492392","reported_name":"Jenkins Kimble L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-02T13:31:07.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":879,"price":3.55,"value":3120.45,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Third Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $3.55 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended June 30, 2020."}],"balance_after":48496,"source":{"system":"sec-edgar","filing":"0001171520-20-000285","document":"doc4_814.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492392/000117152020000285/doc4_814.xml","form_type":"4"}},{"id":3107056,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":144232,"kind":"person","name":"Jenkins Kimble L.","position":1,"cik":"0001492392","reported_name":"Jenkins Kimble L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2020-06-17T16:14:17.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2021 annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":4.13,"expiration_date":"2030-06-03","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001420506-20-000695","document":"doc4_808.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492392/000142050620000695/doc4_808.xml","form_type":"4"}},{"id":3186533,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":144232,"kind":"person","name":"Jenkins Kimble L.","position":1,"cik":"0001492392","reported_name":"Jenkins Kimble L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-02T16:07:18.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":875,"price":3.57,"value":3123.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $3.57 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended March 31, 2020."}],"balance_after":47617,"source":{"system":"sec-edgar","filing":"0001420506-20-000351","document":"doc4_793.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492392/000142050620000351/doc4_793.xml","form_type":"4"}},{"id":3327127,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":144232,"kind":"person","name":"Jenkins Kimble L.","position":1,"cik":"0001492392","reported_name":"Jenkins Kimble L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-02T17:05:33.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":630,"price":4.96,"value":3124.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $4.96 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended December 31, 2019."}],"balance_after":46742,"source":{"system":"sec-edgar","filing":"0001420506-20-000010","document":"doc4_783.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492392/000142050620000010/doc4_783.xml","form_type":"4"}},{"id":3403092,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":144232,"kind":"person","name":"Jenkins Kimble L.","position":1,"cik":"0001492392","reported_name":"Jenkins Kimble L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-01T16:08:44.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":607,"price":5.15,"value":3126.05,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $5.15 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended September 30, 2019."}],"balance_after":46112,"source":{"system":"sec-edgar","filing":"0001534424-19-000271","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492392/000153442419000271/ownership.xml","form_type":"4"}},{"id":3474692,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":144232,"kind":"person","name":"Jenkins Kimble L.","position":1,"cik":"0001492392","reported_name":"Jenkins Kimble L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-01T16:09:16.000Z","date":"2019-06-28","kind":"grant","acquired":true,"shares":987,"price":3.17,"value":3128.79,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $3.17 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended June 28, 2019."}],"balance_after":45505,"source":{"system":"sec-edgar","filing":"0001534424-19-000198","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492392/000153442419000198/ownership.xml","form_type":"4"}},{"id":3495713,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":144232,"kind":"person","name":"Jenkins Kimble L.","position":1,"cik":"0001492392","reported_name":"Jenkins Kimble L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2019-06-10T16:09:17.000Z","date":"2019-06-07","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2020 annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":3.25,"expiration_date":"2029-06-07","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001534424-19-000175","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492392/000153442419000175/ownership.xml","form_type":"4"}},{"id":3568681,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":144232,"kind":"person","name":"Jenkins Kimble L.","position":1,"cik":"0001492392","reported_name":"Jenkins Kimble L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-02T16:09:46.000Z","date":"2019-03-29","kind":"grant","acquired":true,"shares":993,"price":3.15,"value":3127.95,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $3.15 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended March 29, 2019."}],"balance_after":44518,"source":{"system":"sec-edgar","filing":"0001534424-19-000100","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492392/000153442419000100/ownership.xml","form_type":"4"}},{"id":3713216,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":144232,"kind":"person","name":"Jenkins Kimble L.","position":1,"cik":"0001492392","reported_name":"Jenkins Kimble L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-02T17:08:48.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":2125,"price":1.47,"value":3123.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $1.47 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended December 31, 2018."}],"balance_after":43525,"source":{"system":"sec-edgar","filing":"0001534424-19-000010","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492392/000153442419000010/ownership.xml","form_type":"4"}},{"id":3804315,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":144232,"kind":"person","name":"Jenkins Kimble L.","position":1,"cik":"0001492392","reported_name":"Jenkins Kimble L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-01T16:41:38.000Z","date":"2018-09-28","kind":"grant","acquired":true,"shares":1778,"price":1.76,"value":3129.28,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $1.76 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended September 28, 2018."}],"balance_after":41400,"source":{"system":"sec-edgar","filing":"0001534424-18-000337","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492392/000153442418000337/ownership.xml","form_type":"4"}},{"id":3875026,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":144232,"kind":"person","name":"Jenkins Kimble L.","position":1,"cik":"0001492392","reported_name":"Jenkins Kimble L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-03T16:08:03.000Z","date":"2018-06-29","kind":"grant","acquired":true,"shares":1434,"price":2.18,"value":3126.12,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $2.18 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended June 29, 2018."}],"balance_after":39622,"source":{"system":"sec-edgar","filing":"0001534424-18-000240","document":"jenkins.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492392/000153442418000240/jenkins.xml","form_type":"4"}},{"id":3898409,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":144232,"kind":"person","name":"Jenkins Kimble L.","position":1,"cik":"0001492392","reported_name":"Jenkins Kimble L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2018-06-11T08:50:46.000Z","date":"2018-06-08","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2019 annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":2.18,"expiration_date":"2028-06-08","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001534424-18-000208","document":"jenkins.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492392/000153442418000208/jenkins.xml","form_type":"4"}},{"id":3976427,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":144232,"kind":"person","name":"Jenkins Kimble L.","position":1,"cik":"0001492392","reported_name":"Jenkins Kimble L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-02T16:55:55.000Z","date":"2018-03-30","kind":"grant","acquired":true,"shares":997,"price":3.13,"value":3120.61,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $3.13 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended March 29, 2018."}],"balance_after":38188,"source":{"system":"sec-edgar","filing":"0001534424-18-000112","document":"jenkins.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492392/000153442418000112/jenkins.xml","form_type":"4"}},{"id":4088153,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":144232,"kind":"person","name":"Jenkins Kimble L.","position":1,"cik":"0001492392","reported_name":"Jenkins Kimble L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-26T16:09:21.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":1273,"price":2.75,"value":3500.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $2.75 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended December 29, 2017."}],"balance_after":37191,"source":{"system":"sec-edgar","filing":"0001534424-18-000030","document":"jenkins.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492392/000153442418000030/jenkins.xml","form_type":"4"}},{"id":4131720,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":144232,"kind":"person","name":"Jenkins Kimble L.","position":1,"cik":"0001492392","reported_name":"Jenkins Kimble L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2017-12-14T16:21:40.000Z","date":"2017-12-12","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2018 annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":2.75,"expiration_date":"2027-12-12","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001534424-17-000500","document":"jenkins.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492392/000153442417000500/jenkins.xml","form_type":"4"}},{"id":4191018,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":144232,"kind":"person","name":"Jenkins Kimble L.","position":1,"cik":"0001492392","reported_name":"Jenkins Kimble L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2017-10-05T16:05:32.000Z","date":"2017-10-04","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option will vest in full on the first anniversary of the grant date, October 4, 2018."}],"balance_after":300000,"derivative":{"exercise_price":2.6,"expiration_date":"2027-10-04","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001534424-17-000413","document":"jenkins.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492392/000153442417000413/jenkins.xml","form_type":"4"}},{"id":4191017,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":144232,"kind":"person","name":"Jenkins Kimble L.","position":1,"cik":"0001492392","reported_name":"Jenkins Kimble L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-05T16:05:32.000Z","date":"2017-10-04","kind":"grant","acquired":true,"shares":1280,"price":2.47,"value":3161.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $2.47 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended September 29, 2017."}],"balance_after":35918,"source":{"system":"sec-edgar","filing":"0001534424-17-000413","document":"jenkins.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492392/000153442417000413/jenkins.xml","form_type":"4"}},{"id":4301276,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":144232,"kind":"person","name":"Jenkins Kimble L.","position":1,"cik":"0001492392","reported_name":"Jenkins Kimble L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (right to buy)","published_at":"2017-05-30T16:24:16.000Z","date":"2017-05-26","kind":"purchase","acquired":true,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 7,500 units purchased by the Reporting Person for $2.00 per unit. Each unit consists of one share of common stock and one warrant to purchase one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this warrant are immediately exercisable."}],"balance_after":7500,"derivative":{"exercise_price":2.2,"exercise_date":"2017-05-26","expiration_date":"2022-05-26","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001534424-17-000241","document":"jenkins.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492392/000153442417000241/jenkins.xml","form_type":"4"}},{"id":4301275,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":144232,"kind":"person","name":"Jenkins Kimble L.","position":1,"cik":"0001492392","reported_name":"Jenkins Kimble L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-30T16:24:16.000Z","date":"2017-05-26","kind":"purchase","acquired":true,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 7,500 units purchased by the Reporting Person for $2.00 per unit. Each unit consists of one share of common stock and one warrant to purchase one share of common stock."}],"balance_after":34638,"source":{"system":"sec-edgar","filing":"0001534424-17-000241","document":"jenkins.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492392/000153442417000241/jenkins.xml","form_type":"4"}},{"id":4507869,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":144232,"kind":"person","name":"Jenkins Kimble L.","position":1,"cik":"0001492392","reported_name":"Jenkins Kimble L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-03T16:55:16.000Z","date":"2016-12-30","kind":"grant","acquired":true,"shares":701,"price":2.64,"value":1850.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under such plan. The shares were issued at a price of $2.64 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended December 30, 2016."}],"balance_after":27138,"source":{"system":"sec-edgar","filing":"0001534424-17-000014","document":"jenkins.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492392/000153442417000014/jenkins.xml","form_type":"4"}},{"id":4586920,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":144232,"kind":"person","name":"Jenkins Kimble L.","position":1,"cik":"0001492392","reported_name":"Jenkins Kimble L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-04T16:38:42.000Z","date":"2016-09-30","kind":"grant","acquired":true,"shares":425,"price":6.65,"value":2826.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under such plan. The shares were issued at a price of $6.65 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended September 30, 2016."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount corrects a typographical error, which inadvertently overstated the reporting person's holdings, in the previously filed Form 4."}],"balance_after":26437,"source":{"system":"sec-edgar","filing":"0001534424-16-001074","document":"jenkins.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492392/000153442416001074/jenkins.xml","form_type":"4"}}]}